Wordt geladen...
Comparative safety of biologic versus conventional synthetic DMARDs in rheumatoid arthritis with COPD: a real-world population study
OBJECTIVES: Abatacept, a biologic DMARD, was associated with respiratory adverse events in a small subgroup of RA patients with chronic obstructive pulmonary disease (COPD) in a trial. Whether this potential risk is specific to abatacept or extends to all biologics and targeted synthetic DMARDs (tsD...
Bewaard in:
| Gepubliceerd in: | Rheumatology (Oxford) |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7188346/ https://ncbi.nlm.nih.gov/pubmed/31504972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez359 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|